Skip to content

Site logo

Main menu
  • Company
    • Company overview
    • Stories
    • History
    • Environmental, Social & Governance (ESG)
      • ESG overview
      • Philanthropy
      • Merck Medical Outreach Program
      • Impact investing
      • Transparency disclosures
      • ESG resources
    • Leadership
      • Leadership overview
      • Board of directors
      • Executive team
    • Culture & values
      • Culture & values overview
      • Code of conduct & compliance
    • Diversity & inclusion
    • Policies & positions
    • Business development & licensing
    • Suppliers
      • Suppliers overview
      • Supplier registration
      • Supplier help for Ariba
  • Research
    • Research overview
    • Areas of focus
      • Oncology
      • Vaccines
      • Infectious diseases
      • Cardio-metabolic disorders
    • Pipeline
    • Discovery & development
    • R&D locations
    • Clinical trials
      • Clinical trials overview
      • Find a trial
      • Diversity in clinical trials
  • Products
    • Products list
    • Safety data sheets
    • Product patents
    • Merck authorized distributors
  • Patients
    • Patients overview
    • Patient support programs
    • Patient resources
    • Patient & treatment education
  • Careers
    • Careers
    • Search jobs
    • Our divisions
      • Research & development
      • Manufacturing & supply
      • Human Health
      • Animal Health
      • Global support functions
    • Veterans
    • Student opportunities
    • Compensation & benefits
    • How we hire
    • MSD Careers
    • Events
    • Talent community
  • Investors
    • Investors overview
    • Events & presentations
    • Financial information
      • Financial information overview
      • SEC filings
    • Stock information
    • Investor resources
      • Investor resources overview
      • Organon resources
      • Request for information
  • Media
    • Media overview
    • News releases
    • Company statements
    • Media library & contacts
    • Company fact sheet
two scientists wearing masks

Our COVID-19 efforts

Learn more
Contact us

Worldwide Countries outside of the United States and Canada.

What can we help you find?

Search for:
Environmental, Social & Governance

Merck hosts supplier diversity summit

At the 2022 Billion Dollar Roundtable Summit, company leaders shared the importance of supplier diversity, how we're leading our industry and making a difference for the world

September 7, 2022

Share this article

supplier diversity illustration

Our company hosted the recent Billion Dollar Roundtable (BDR) summit, an annual event that brings together companies dedicated to supporting supplier diversity. Our global supplier management group (GSMG), global diversity & inclusion (GD&I), health equity, environment, social and governance (ESG), global workplace enterprise services (GWES) and government relations teams are among those working together to advance our commitment to supplier diversity and economic inclusion and our partnership with BDR.

Company executives including EVP and Chief Financial Officer Caroline Litchfield, SVP of GSMG and Chief Procurement Officer Susanna Webber, and GD&I VP Celeste Warren joined leaders from other member organizations for the two-day event in New Jersey. 

The BDR was founded in 2001 to recognize corporations that spend at least $1 billion annually with women- and minority-owned suppliers, influencing and shaping supplier diversity excellence globally. Our company, which was inducted into the organization in 2017, spent $2.9 billion with diverse suppliers globally this past year — driving more than $5 billion in economic impact and helping to sustain more than 30,000 jobs in the U.S.  

Celeste Warren
Celeste Warren, GD&I VP

“We know that sourcing products and services from diverse suppliers creates jobs and increases economic opportunities for underrepresented communities,” Warren said in her welcome remarks. “It’s part of our commitment to D&I, to ESG — and it’s just good business. To understand our diverse customers and to engage with them in pursuit of our work to help save and improve lives, we must have diverse perspectives at the table. That means embracing diversity within our own team and with our supplier partners.” 

Supplier diversity is key to ESG

The BDR Summit focused on ESG issues and corporate social responsibility. 

“Fostering diversity and inclusion takes more than wishful thinking; it takes intention and action,” said CEO and President Rob Davis in a video address. “We have been intentionally seeking goods and services from diverse suppliers for 37 years. And over time, our progress has expanded to focus not only nationally but globally. Supplier diversity is key to fulfilling our purpose and lies at the center of our diversity and inclusion efforts. It’s also key as an element of our overall ESG focus as a company.” 

Rob Davis
Rob Davis, CEO and president

Company leaders in conversation 

Company leaders took part in sessions to talk about how supplier diversity fits into our ESG strategy and share best practices. 

Litchfield joined BDR Chairman Shelley Stewart to discuss the many ways we’re working to be a leader in ESG, starting with equitable health access.  

“To be successful in advancing health equity, we need to look outside our company and partner with organizations who are on the ground and understand local community context,” Litchfield said.  

She added that working with diverse suppliers not only creates economic opportunities for underrepresented communities, but it also benefits patients.  

“We will best serve this world if we have an employee base and supplier base that mirrors the patients we are trying to serve,” Litchfield said. “We’ve embarked on that journey, but there’s much more we need to do.” 

Caroline Litchfield
Caroline Litchfield, EVP and chief financial officer
Josette Gbemudu
Josette Gbemudu, executive director, health equity

Josette Gbemudu, executive director, health equity, gave a talk illustrating how spending with diverse suppliers advances health equity. Creating economic opportunities for underrepresented communities leads to higher household incomes, better high school and college graduation rates, more access to healthy foods and lower infant and child mortality rates, among other benefits.  

By supporting diverse suppliers, Gbemudu told attendees, companies are “impacting people in a very real way on a day-to-day basis.” 

Kyra Lanza, AVP, ESG strategy & engagement, joined a panel with representatives from J&J, JPMorgan Chase & Co. and Boeing to share insights about developing their company’s ESG frameworks.  

“Companies like ours are listening,” Lanza said. “We want to hear from you on how we can get through challenges so my children and your children wake up in a different world, a place that you as a supplier can make a difference.”   

Kyra Lanza
Kyra Lanza, AVP, ESG strategy & engagement
Susanna Webber
Susanna Webber, SVP of GSMG and chief procurement officer

Webber sat down with Ted Baumuller, VP of source to pay at Meta, to talk about how they embed the principles of citizenship and responsible sourcing into their organizations.  

“Our company’s goal was always to be a part of the BDR,” said Webber. “Now that we have a seat at the table, we have to look ahead to determine what our long-term goal is. Supplier diversity is a big part of who we are as a company, and we can’t risk it getting lost. We have a responsibility to keep supplier diversity as a paramount position within our overall ESG focus. We have to have the leadership to stretch ourselves even further.” 

Discover more stories

Pride, pediatrics and parenting

New podcast: Meet the dealmakers 

Safeguarding the environment through green chemistry

View all stories

Explore more in

Collaboration
Corporate responsibility
Leadership perspective
Sustainability

Related links

related content image #1

Environmental, Social & Governance (ESG)

Supporting society, people and communities around the world is fundamental to our long-term success

related content image #2

Our culture and values

It all comes back to saving and improving lives

related content image #3

About our company

Discover how we invent for life

Connect with us on social

social icon social icon social icon social icon social icon
  • MerckHelps
    Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients
  • Merck Access Program
    Information about insurance coverage and financial assistance options for eligible patients
  • Clinical trials
    Learn about our clinical trials and find available studies
  • Merck Manuals
    Medical information source covering thousands of topics in all fields of medicine
  • Environmental, Social & Governance (ESG) Report
    Reporting on our commitment to operating responsibly to benefit society
  • Merck for Mothers
    An initiative to create a world where no woman has to die giving life
  • Merck Animal Health
    The global animal health business unit of Merck
  • Health Plan - Transparency in Coverage
    In compliance with the Consolidated Appropriations Act, learn more about our health plan's pricing information.
  • Forward-looking statement
  • Cookie policy
  • Privacy
  • Transparency disclosure
  • Terms of use
  • Accessibility
  • Sitemap
Copyright © 2023 Merck & Co., Inc., Rahway, NJ USA, and its affiliates. All rights reserved. | This site is intended only for residents of the United States and Canada.
Accessibility icon View Privacy Shield Verification Status View APEC CBPR Privacy Certification Status

Forward-looking statement of Merck & Co., Inc., Rahway, N.J., USA

This website of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2022 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update
The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept

You are leaving Merck.com

Continue

Welcome to Merck.com

By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co Inc, Rahway, NJ USA.

Continue